Skip to content
Lower risk Medical device recall · FDA · Published July 21, 2025

Stago STA-Liquid Anti-Xa 4 kits may contaminate heparin tests

Stago recalls STA-Liquid Anti-Xa 4 kits (model 00311US) due to potential contamination with fibrinogen reagents in heparin tests. Affected users should contact Stago for details.

🇺🇸 FDA recall #Z-2474-2025Medical deviceStago ›
Take action

Contact the company

Recalling firmDiagnostica Stago, Inc.5 Century Dr · Parsippany, NJ 07054-4607
✎ GovInfoNow plain-language explainer

What happened, in plain English

Stago recalls its STA-Liquid Anti-Xa 4 kits (model 00311US) because they might mix with fibrinogen reagents used in heparin tests. This could lead to inaccurate test results if the kits are used with certain analyzers. Read more at govinfonow.com/recall/51764-stago-sta-liquid-anti-xa-4-kits-may-contaminate-heparin.

Source Summary by GovInfoNow · govinfonow.com/recall/51764-stago-sta-liquid-anti-xa-4-kits-may-contaminate-heparin · Updated August 17, 2026 · FDA enforcement record: FDA #Z-2474-2025

Cite this page

“Stago STA-Liquid Anti-Xa 4 kits may contaminate heparin tests.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/51764-stago-sta-liquid-anti-xa-4-kits-may-contaminate-heparin. Based on FDA recall #Z-2474-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2474-2025%22&limit=1).

Why it’s dangerous

The kits could mix with fibrinogen reagents used in unfractionated heparin (UFH) and low molecular weight heparin (LMWH) tests. This contamination might cause inaccurate test results, but it does not cause direct harm to users.

Who’s affected

Healthcare professionals using Stago's STA-Liquid Anti-Xa 4 kits for heparin level testing with specific analyzers are most at risk. Patients receiving these tests may be affected if the kits are used incorrectly.

How to tell if you have this one

Check for the model number 00311US on the kit packaging. The kits are intended for use with Stago STA-R, STA Compact, or STA Satellite analyzers for heparin level testing.

  • Brand
    Stago
  • Category
    Medical device
FDA recall event · 4 products

All 4 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Worldwide - US Nationwide distribution in the states of AL, AZ, CA, CO, FL, GA, LA, MD, ME, MN, MO, MT, NC, OH, OK, OR, PA, PR, SD, VT, WI, WY and the countries of Algeria, Argentina, Austria, Brazil, Bulgaria, Canada, Chile, Colombia, Costa Rica, France, French Polynesie, Guadeloupe, India, Iran, Israel, Jordan, Korea, Kuwait, Lebanon, Malaysia, Mexico, Morocco, Netherlands, Oman, Paraguay, Peru, Republique Tcheque, Romania, Saudi Arabia, Serbia, South Africa, Switzerland, Taiwan, Thailand, Tunisia, Turquie, United Arab Emirates, Uruguay, Vietnam.
Recall numberProduct, codes & lotsQuantity
Z-2473-2025STA Satellite. Product Code: All references. All software versions. The STA Satellite is a fully automated benchtop analyzer capable of simultaneously performing clotting, chromogenic, and immunologic assays.; Product Code: All references. UDI-DI: 03607450581041, 03607450581027. All software versions.3,650 units (538 US)
Z-2474-2025STA-Liquid Anti-Xa 4. Model/Catalog Number: 00311US. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite analyzers, for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate.; Model/Catalog Number: 00311US. UDI-DI: 03607450011784.116,600 units (114,600 US)
Z-2475-2025STA-Liquid Anti-Xa 8. Model/Catalog Number: 00322US. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite analyzers, for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate.; Model/Catalog Number: 00322US. UDI-DI: 03607450011791126,200 units (125,900 US)
Z-2476-2025STA - Fibrinogen 5. Model/Catalog Number: 00674. The STA - Fibrinogen 5 kit is intended for use with the analyzers of the STA-R, STA Compact and STA Satellite families for the quantitative determination of fibrinogen levels in human citrated plasma by the clotting method of Clauss.; Model/Catalog Number: 00674. UDI-DI: 13607450006749829,800 units (245,200 US)
Based on the official FDA remedy

What to do — step by step

  1. Contact Stago

    Reach out to Stago directly for specific instructions on how to handle the recalled kits.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 21 states.

Alaska: nationwideAKMaine: named in the noticeMEVermont: named in the noticeVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: named in the noticeMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: nationwideILWisconsin: named in the noticeWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: named in the noticeORNevada: nationwideNVWyoming: named in the noticeWYSouth Dakota: named in the noticeSDIowa: nationwideIAIndiana: nationwideINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: named in the noticeCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: named in the noticeNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: nationwideTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide - US Nationwide distribution in the states of AL, AZ, CA, CO, FL, GA, LA, MD, ME, MN, MO, MT, NC, OH, OK, OR, PA, PR, SD, VT, WI, WY and the countries of Algeria, Argentina, Austria, Brazil, Bulgaria, Canada, Chile, Colombia,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, California, Colorado, Florida, Georgia, Louisiana, Maine, Maryland, Minnesota, Missouri, Montana, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, South Dakota, Vermont, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 44 days after the firm started it.

1. Firm started the recall: Jul 21, 202512. FDA classified it Class II: Aug 29, 202523. Published in FDA’s Enforcement Report: Sep 3, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2474-2025 (July 21, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2474-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA